134 related articles for article (PubMed ID: 8612115)
1. Effects of theophylline and ipratropium on cognition in elderly patients with chronic obstructive pulmonary disease.
Ramsdell JW; Henderson S; Renvall MJ; Salmon DP; Ferguson P
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):335-40. PubMed ID: 8612115
[TBL] [Abstract][Full Text] [Related]
2. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Lee TA; Schumock GT; Bartle B; Pickard AS
Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
[TBL] [Abstract][Full Text] [Related]
3. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
[TBL] [Abstract][Full Text] [Related]
4. [Comparing the bronchodilating effects of ipratropium bromide and theophylline].
Dai L; Li X; Yang Y
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):609-11. PubMed ID: 11477880
[TBL] [Abstract][Full Text] [Related]
5. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
Eiser NM; Phillips C; Wooler PA
Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
[TBL] [Abstract][Full Text] [Related]
6. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
Balkissoon R; Make B
COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
[TBL] [Abstract][Full Text] [Related]
7. The role of domiciliary nebulizers in managing patients with severe COPD.
Eiser N; Angus K; McHale S
Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
[TBL] [Abstract][Full Text] [Related]
8. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E
Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary diseases.
Gupta RK; Chhabra SK
Indian J Chest Dis Allied Sci; 2002; 44(3):165-72. PubMed ID: 12206475
[TBL] [Abstract][Full Text] [Related]
10. [A comparison of bronchodilating drugs in the treatment of stable COPD].
Nishimura K; Koyama H; Izumi T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):835-43. PubMed ID: 1385837
[TBL] [Abstract][Full Text] [Related]
11. [Effect of ipratropium bromide on histamine-induced bronchoconstriction in subjects with chronic airway obstruction].
Nannini LJ
Medicina (B Aires); 2001; 61(3):262-6. PubMed ID: 11474870
[TBL] [Abstract][Full Text] [Related]
12. Physiological and neuropsychological effects of theophylline in chronic obstructive pulmonary disease.
Newman D; Tamir J; Speedy L; Newman JP; Ben-Dov I
Isr J Med Sci; 1994 Nov; 30(11):811-6. PubMed ID: 7982769
[TBL] [Abstract][Full Text] [Related]
13. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis.
Dockhorn R; Aaronson D; Bronsky E; Chervinsky P; Cohen R; Ehtessabian R; Finn A; Grossman J; Howland W; Kaiser H; Pearlman D; Sublett J; Ratner P; Settipane G; Sim T; Storms W; Webb R; Drda K; Wood C
Ann Allergy Asthma Immunol; 1999 Apr; 82(4):349-59. PubMed ID: 10227333
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the bronchodilatating effects of ipratropium and terbutalin inhaled with Monaghan IPPB-M 515 by 19 patients with chronic obstructive airways disease.
Petersen BN; Weeke E
Scand J Respir Dis Suppl; 1979; 103():178-82. PubMed ID: 155295
[TBL] [Abstract][Full Text] [Related]
15. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
[TBL] [Abstract][Full Text] [Related]
16. The effects of theophylline on metabolic rate in chronic obstructive lung disease patients.
Mosier K; Renvall MJ; Ramsdell JW; Spindler AA
J Am Coll Nutr; 1996 Aug; 15(4):403-7. PubMed ID: 8829097
[TBL] [Abstract][Full Text] [Related]
17. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
18. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.
Tsukino M; Nishimura K; Ikeda A; Hajiro T; Koyama H; Izumi T
Thorax; 1998 Apr; 53(4):269-73. PubMed ID: 9741369
[TBL] [Abstract][Full Text] [Related]
19. Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease.
Bleecker ER; Britt EJ
Am J Med; 1991 Oct; 91(4A):24S-27S. PubMed ID: 1835291
[TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease.
Murciano D; Auclair MH; Pariente R; Aubier M
N Engl J Med; 1989 Jun; 320(23):1521-5. PubMed ID: 2498658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
